Murine Monoclonal Antibody Market Poised for Rapid Growth: Global Market Size, Share, and Forecast 2026-2032
Global Leading Market Research Publisher QYResearch announces the release of its latest report “Murine Monoclonal Antibody – Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032”. Based on historical analysis (2021-2025) and forecast calculations (2026-2032), this report provides a comprehensive market research study, covering market size, market share, demand trends, industry development status, and future growth prospects for the global Murine Monoclonal Antibody market.
【Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)】
https://www.qyresearch.com/reports/6117364/murine-monoclonal-antibody
Global Market Overview
The global Murine Monoclonal Antibody market was valued at US$ 14 million in 2025 and is expected to reach US$ 30.62 million by 2032, with a CAGR of 12.0% over the forecast period. In 2024, total sales volume reached approximately 125,000 units, with an average unit price of US$ per unit, a single-line production capacity of 20,000 units, and a gross profit margin of 85%.
Mouse-derived monoclonal antibodies (mAbs) are highly specific antibodies produced using the mouse immune system through hybridoma technology. They are created by fusing immunized mouse spleen cells with myeloma cells, selecting hybridoma lines that secrete antibodies against specific antigens, enabling stable, large-scale production. These antibodies are characterized by high specificity, high affinity, and consistent batch-to-batch performance, making them indispensable for biomedical research, disease diagnosis, vaccine development, and early antibody drug screening.
Market Applications and Insights
Despite the rise of humanized and fully human antibody technologies, murine monoclonal antibodies remain essential for:
- Basic life science research – Mouse models provide a mature and cost-effective platform for developing and studying new antibodies.
- In vitro diagnostics (IVD) – High batch-to-batch stability and low production costs make mouse mAbs ideal as capture or detection antibodies in ELISA kits and rapid diagnostic tests.
- Drug discovery and therapeutic development – While their high immunogenicity limits direct clinical use, murine mAbs are crucial as lead candidates for subsequent engineering into chimeric or humanized antibodies, extending their commercial and clinical value.
Industry Structure and Cost Insights
The production and supply chain include:
- Upstream: Mouse hybridoma cell lines, cell culture media, purification reagents, and lab equipment
- Midstream: Antibody screening, hybridoma expansion, purification, formulation, and quality control
- Downstream: Biopharmaceutical laboratories, universities, and diagnostic companies
Cost structure: Raw materials and reagents account for the majority of production costs, while labor, equipment, and quality control constitute the remainder. The high-profit margin reflects the market’s specialized nature and strong demand.
Market Segmentation
By Type:
- 2KU
- 10KU
- 20KU
- 100KU
- Others
By Application:
- Biopharmaceutical Laboratories
- University Laboratories
- Others
Market Outlook and Development Trends
The Murine Monoclonal Antibody market continues to demonstrate strong growth potential, driven by:
- Expanding basic and applied life sciences research worldwide
- Increasing demand in diagnostics and early-stage therapeutic development
- Adoption of advanced hybridoma and screening technologies
- Growing integration with chimeric and humanized antibody pipelines for drug development
The industry outlook indicates stable and high-value growth, particularly in biopharmaceutical R&D hubs across North America, Europe, and Asia-Pacific. Murine mAbs maintain a strategic role as foundational tools for antibody discovery and diagnostics, ensuring ongoing relevance in the market.
Leading Market Players
- Thermo Fisher Scientific
- Promega Corporation
- New England Biolabs
- Roche
- QIAGEN GmbH
- Merck
- Bio-Rad Laboratories
- AMSBIO
- TIANGEN Biotech
- Amyjet Scientific
- Vazyme Biotech
- Bioer Technology
- Yeasen
- RayBiotech, Inc.
- Enzynomics
Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
EN: https://www.qyresearch.com
E-mail: global@qyresearch.com
Tel: 001-626-842-1666(US)
JP: https://www.qyresearch.co.jp
